Company

Sihuan Pharmaceutical

As of the edition of 20 October 2026, Sihuan Pharmaceutical runs 5 drugs; it is on route A at 4 targets and on route B at 0 targets.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

Route A at 4 targets, route B at 0 targets.

Three of its 4 rows, by target and route
Target	Route
ERBB4 Receptor tyrosine-protein kinase erbB-4	Route A
ERBB3 Receptor tyrosine-protein kinase erbB-3	Route A
ERBB2 Receptor tyrosine-protein kinase erbB-2	Route A

In the product

4 company-target rows on route A or B; 1 is not shown here, and no score is.